Blake Anson - Publications

Affiliations: 
 

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Anson B, Delaura S, Jones E, Mann DA. Enabling Phenotypic Screening Genetic Engineering and Biotechnology News. 36: 14-15. DOI: 10.1089/gen.36.01.09  0.48
2015 Drowley L, Koonce C, Peel S, Jonebring A, Plowright AT, Kattman SJ, Andersson H, Anson B, Swanson BJ, Wang QD, Brolen G. Human iPSC-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation. Stem Cells Translational Medicine. PMID 26683871 DOI: 10.5966/sctm.2015-0114  0.48
2015 Beauchamp P, Moritz W, Kelm JM, Ullrich ND, Agarkova I, Anson BD, Suter TM, Zuppinger C. Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes. Tissue Engineering. Part C, Methods. 21: 852-61. PMID 25654582 DOI: 10.1089/ten.TEC.2014.0376  0.48
2015 Anson B. Building richer assays Genetic Engineering and Biotechnology News. 35: 20-21. DOI: 10.1089/gen.35.02.10  0.48
2013 Carlson C, Koonce C, Aoyama N, Einhorn S, Fiene S, Thompson A, Swanson B, Anson B, Kattman S. Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy. Journal of Biomolecular Screening. 18: 1203-11. PMID 24071917 DOI: 10.1177/1087057113500812  0.48
2013 Puppala D, Collis LP, Sun SZ, Bonato V, Chen X, Anson B, Pletcher M, Fermini B, Engle SJ. Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue. Toxicological Sciences : An Official Journal of the Society of Toxicology. 131: 292-301. PMID 22982684 DOI: 10.1093/toxsci/kfs282  0.48
2013 Sirenko O, Crittenden C, Callamaras N, Hesley J, Chen YW, Funes C, Rusyn I, Anson B, Cromwell EF. Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells. Journal of Biomolecular Screening. 18: 39-53. PMID 22972846 DOI: 10.1177/1087057112457590  0.48
2013 Iacone R, Anson B. Patient in a dish Ebr - European Biopharmaceutical Review. 56-60.  0.48
2012 Rana P, Anson B, Engle S, Will Y. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicological Sciences : An Official Journal of the Society of Toxicology. 130: 117-31. PMID 22843568 DOI: 10.1093/toxsci/kfs233  0.48
2011 Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, Kamp TJ, Kolaja KL, Swanson BJ, January CT. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. American Journal of Physiology. Heart and Circulatory Physiology. 301: H2006-17. PMID 21890694 DOI: 10.1152/ajpheart.00694.2011  0.48
2011 Anson BD, Kolaja KL, Kamp TJ. Opportunities for use of human iPS cells in predictive toxicology. Clinical Pharmacology and Therapeutics. 89: 754-8. PMID 21430658 DOI: 10.1038/clpt.2011.9  0.48
2011 Kattman SJ, Koonce CH, Swanson BJ, Anson BD. Stem cells and their derivatives: a renaissance in cardiovascular translational research. Journal of Cardiovascular Translational Research. 4: 66-72. PMID 21061105 DOI: 10.1007/s12265-010-9235-1  0.48
2011 Ott V, Anson B. Stem cell innovation Ebr - European Biopharmaceutical Review. 38-43.  0.48
2010 Lin EC, Holzem KM, Anson BD, Moungey BM, Balijepalli SY, Tester DJ, Ackerman MJ, Delisle BP, Balijepalli RC, January CT. Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes. American Journal of Physiology. Heart and Circulatory Physiology. 298: H1842-9. PMID 20363883 DOI: 10.1152/ajpheart.01236.2009  0.48
2010 Anson B. iPSC-derived human cardiomyocytes Genetic Engineering and Biotechnology News. 30.  0.48
2009 Anson BD, Ma J, He JQ. Identifying cardiotoxic compounds human ips cell-derived cardiomyocytes (and other cell types) streamline quest for novel drug candidates Genetic Engineering and Biotechnology News. 29.  0.48
2006 Rajamani S, Eckhardt LL, Valdivia CR, Klemens CA, Gillman BM, Anderson CL, Holzem KM, Delisle BP, Anson BD, Makielski JC, January CT. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. British Journal of Pharmacology. 149: 481-9. PMID 16967046 DOI: 10.1038/sj.bjp.0706892  0.48
2006 Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ, Gong Q, Zhou Z, Ackerman MJ, January CT. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation. 113: 365-73. PMID 16432067 DOI: 10.1161/CIRCULATIONAHA.105.570200  0.48
2006 Kawakami K, Nagatomo T, Abe H, Kikuchi K, Takemasa H, Anson BD, Delisle BP, January CT, Nakashima Y. Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy. British Journal of Pharmacology. 147: 642-52. PMID 16314852 DOI: 10.1038/sj.bjp.0706508  0.48
2006 Rajamani S, Anderson CL, Valdivia CR, Eckhardt LL, Foell JD, Robertson GA, Kamp TJ, Makielski JC, Anson BD, January CT. Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and I(Kr). American Journal of Physiology. Heart and Circulatory Physiology. 290: H1278-88. PMID 16227340 DOI: 10.1152/ajpheart.00777.2005  0.48
2005 Delisle BP, Slind JK, Kilby JA, Anderson CL, Anson BD, Balijepalli RC, Tester DJ, Ackerman MJ, Kamp TJ, January CT. Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome. Molecular Pharmacology. 68: 233-40. PMID 15851652 DOI: 10.1124/mol.105.012914  0.48
2005 Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, Badley AD. Blockade of HERG channels by HIV protease inhibitors. Lancet (London, England). 365: 682-6. PMID 15721475 DOI: 10.1016/S0140-6736(05)17950-1  0.48
2004 Zhang L, Vincent GM, Baralle M, Baralle FE, Anson BD, Benson DW, Whiting B, Timothy KW, Carlquist J, January CT, Keating MT, Splawski I. An intronic mutation causes long QT syndrome. Journal of the American College of Cardiology. 44: 1283-91. PMID 15364333 DOI: 10.1016/j.jacc.2004.06.045  0.48
2004 Delisle BP, Anson BD, Rajamani S, January CT. Biology of cardiac arrhythmias: ion channel protein trafficking. Circulation Research. 94: 1418-28. PMID 15192037 DOI: 10.1161/01.RES.0000128561.28701.ea  0.48
2004 Anson BD, Ackerman MJ, Tester DJ, Will ML, Delisle BP, Anderson CL, January CT. Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels. American Journal of Physiology. Heart and Circulatory Physiology. 286: H2434-41. PMID 14975928 DOI: 10.1152/ajpheart.00891.2003  0.48
2003 Delisle BP, Anderson CL, Balijepalli RC, Anson BD, Kamp TJ, January CT. Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C. The Journal of Biological Chemistry. 278: 35749-54. PMID 12837749 DOI: 10.1074/jbc.M305787200  0.48
2003 Keyser MR, Anson BD, Titus SA, Ganetzky B, Witten JL. Molecular characterization, functional expression, and developmental profile of an ether à-go-go K+ channel in the tobacco hornworm Manduca sexta. Journal of Neurobiology. 55: 73-85. PMID 12605460 DOI: 10.1002/neu.10188  0.48
2002 Mbai M, Rajamani S, Delisle BP, Anson BD, Anderson C, Makielski JC, January CT. Genetic basis for the origin of cardiac arrhythmias: implications for therapy. Current Cardiology Reports. 4: 411-7. PMID 12169238 DOI: 10.1007/s11886-002-0041-5  0.48
2002 Rajamani S, Anderson CL, Anson BD, January CT. Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block. Circulation. 105: 2830-5. PMID 12070109 DOI: 10.1161/01.CIR.0000019513.50928.74  0.48
2001 Anson BD, Roberts WM. Sodium channel distribution on uninnervated and innervated embryonic skeletal myotubes. Journal of Neurobiology. 48: 42-57. PMID 11391648 DOI: 10.1002/neu.1041  0.48
1998 Anson BD, Roberts WM. A novel voltage clamp technique for mapping ionic currents from cultured skeletal myotubes. Biophysical Journal. 74: 2963-72. PMID 9635750 DOI: 10.1016/S0006-3495(98)78003-8  0.48
1990 Lindroth RL, Anson BD, Weisbrod AV. Effects of protein and juglone on gypsy moths: Growth performance and detoxification enzyme activity. Journal of Chemical Ecology. 16: 2533-47. PMID 24264218 DOI: 10.1007/BF01017476  0.48
Show low-probability matches.